Reckitt Benckiser stock holds steady as the consumer group stays in focus
Published on 07/14/2026 at 03:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Reckitt Benckiser (ISIN GB00B24CGK77) remains a London-listed consumer staples group whose portfolio spans hygiene, health and nutrition brands sold worldwide.
Business model
The company sells everyday products under brands such as Dettol, Nurofen, Strepsils, Finish, Vanish and Durex, which gives the business a defensive profile that often looks different from discretionary consumer names.
Market context
For US investors, the key read-through is that Reckitt Benckiser sits in the global consumer health and household-products lane, where pricing power, brand strength and supply-chain execution usually matter more than a single headline catalyst.
Representative products
Dettol disinfectants are part of the company's hygiene franchise, while Durex remains one of its best-known sexual wellness brands.
Shares and venue
Reckitt Benckiser shares trade on the London Stock Exchange in sterling. The stock is priced at GBP 0.00 as of July 14, 2026, 1:46 a.m. UTC.
Fact box
- Company: Reckitt Benckiser Group plc
- ISIN: GB00B24CGK77
- Ticker: RKT
- Exchange: London Stock Exchange
- Price (as of July 14, 2026, 1:46 a.m. UTC): GBP 0.00
- Sector / Industry: Consumer Staples, Household & Personal Products
- Index membership: FTSE 100
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
